to Committee on Committees (S)
Summary
The bill mandates that Kentucky health insurance plans add generic drugs and biosimilar biologics to their drug lists with lower out‑of‑pocket costs and no prior‑authorization limits whenever those products cost less than the brand or reference product they replace. It affects any health plan that provides prescription drug coverage, as well as pharmacies, insurers, and patients who will gain easier access to lower‑priced medicines.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when SB 211 changes status, plus AI-powered summaries and stage predictions.
Sign up free